Abstract
There is an increasing need for novel biomarkers that enable better diagnostic and prognostic stratification of patients with suspected infection. A proprotein convertase enzyme FURIN is upregulated upon immune cell activation, and it promotes infectivity by cleaving and activating pathogens. In this study, we determined FURIN levels in plasma using ELISA from 537 patients that were admitted to emergency room with suspected infection. Patients were sorted to high- and low-level FURIN groups with a cut-off level of 370 pg/ml. The study cohort included five diagnostic groups: Group 1, no systemic inflammatory response syndrome (SIRS, n = 59 patients); Group 2, bacterial infection without SIRS (n = 67); Group 3, SIRS, but no bacterial infection (n = 308); Group 4, sepsis without organ failure (n = 308); and Group 5, severe sepsis (n = 49). Statistically significant associations were not found between the plasma level of FURIN and the prevalence of sepsis (P = 0.957), diagnostic group of a patient (P = 0.737) or the bacteria in blood culture (P = 0.499). Additionally, the concentration of FURIN did not predict the severity or case fatality of the infectious disease. However, statistically significant associations were found between...Continue Reading
References
Jun 1, 1992·Chest·R C BoneC L Sprung
Dec 14, 1999·The Journal of Emergency Medicine·B Clyne, J S Olshaker
Jul 11, 2001·Critical Care Medicine·D C AngusM R Pinsky
Oct 3, 2002·Nature Reviews. Molecular Cell Biology·Gary Thomas
Jan 10, 2003·The New England Journal of Medicine·Richard S Hotchkiss, Irene E Karl
Sep 17, 2003·Critical Care : the Official Journal of the Critical Care Forum·Herwig Gerlach, Didier Keh
Apr 22, 2006·Blood·Marko PesuJohn J O'Shea
Oct 3, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nathalie ScamuffaAbdel-Majid Khatib
Jun 1, 2007·The Journal of Biological Chemistry·Sergey A ShiryaevAlex Y Strongin
Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Aug 15, 2008·Nature·Marko PesuJohn J O'Shea
Jan 27, 2009·Intensive Care Medicine·Joana SilvestreH Sabino
Aug 17, 2010·BMC Medical Genetics·Nanfang LiJianhang Chang
Aug 31, 2011·Journal of Dental Research·J LeeR Vassallo
Sep 6, 2011·Atherosclerosis·Hannu TurpeinenMarko Pesu
Sep 7, 2011·Scandinavian Journal of Infectious Diseases·Raija Uusitalo-SeppäläEsa M Rintala
Dec 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Neil SenzerJohn Nemunaitis
Feb 15, 2012·Oncogene·S M CorkE G Van Meir
May 19, 2012·Arthritis and Rheumatism·Hilène LinMartine Cohen-Solal
Jun 12, 2012·Scandinavian Journal of Infectious Diseases·Raija Uusitalo-SeppäläEsa M Rintala
Jul 5, 2012·Journal of Internal Medicine·R Uusitalo-SeppäläE M Rintala
Jan 24, 2013·PloS One·Raija Uusitalo-SeppäläEsa M Rintala
Apr 27, 2013·Science·Felix MeissnerMatthias Mann
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Oct 22, 2013·Immunity·Madeleine M HippVincenzo Cerundolo
Nov 22, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Dec 3, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abhai KumarGopal Nath
Jan 8, 2014·Current Genomics·Hannu TurpeinenMarko Pesu
Oct 31, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anna OksanenMarko Pesu
Citations
Nov 27, 2018·Scandinavian Journal of Rheumatology·A ValliP Isomäki
Jan 9, 2019·Intensive Care Medicine Experimental·Jane FisherPeter Bentzer
Aug 26, 2020·Journal of Clinical Laboratory Analysis·Rong CaoBo Shen
Nov 19, 2020·Journal of Lipid Research·Carlota OleagaSergio Fazio
Jan 12, 2021·Journal of Lipid Research·Carlota OleagaSergio Fazio
Mar 2, 2021·Frontiers in Medicine·Thomas GraierPeter Wolf
Nov 28, 2021·Nature Reviews. Urology·R Clayton Edenfield, Charles A Easley